Performance of the new HIV-1/2 Diagnostic Algorithm in Florida's public health testing population: A review of the first five months of utilization

Journal of Clinical Virology

Volumn 58, Issue SUPPL1, 2013, Pages

  Bennett, Berry ^a   Neumann, Dana ^a   Fordan, Sally ^a   Villaraza, Rowena ^a   Crowe, Susanne ^a   Gillis, Leah ^a  

^a FLORIDA DEPARTMENT OF HEALTH   (United States)

Author keywords

HIV; New HIV Diagnostic Algorithm; Public health

Indexed keywords

ALGORITHM; ARTICLE; BLOOD SAMPLING; HIV 1/2 ANTIGEN ANTIBODY IMMUNOASSAY; HIV TEST; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNOASSAY; IMMUNOLOGY TEST KIT; MULTISPOT HIV 1/HIV 2 RAPID TEST; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; TURNAROUND TIME; WESTERN BLOTTING;

HIV; NEW HIV DIAGNOSTIC ALGORITHM; PUBLIC HEALTH;

ALGORITHMS; DIAGNOSTIC TESTS, ROUTINE; FLORIDA; HIV ANTIBODIES; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; IMMUNOASSAY; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIROLOGY;

EID: 84890220952     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.08.016     Document Type: Article

References (20)

1. Tripathi A., Gardner L., Ogbuanu I., et al. Predictors of time to enter medical care after a new HIV diagnosis: a statewide population-based study. AIDS Care 2011, 23(11):1366-1373.
2. Pandori M.W., Branson B.M. HIV diagnostic conference. Expert Rev Anti Infect Ther 2010, 8(6):631-633.
3. Branson B.M. The future of HIV testing. J Acquir Immune Defic Syndr 2010, 55(Suppl 2):S102-S105.
4. Branson B.M., Mermin J. Establishing the diagnosis of HIV infection: new tests and a new algorithm for the United States. J Clin Virol 2011, 52(Suppl 1):S3-S4.
5. Detection of acute HIV infection in two evaluations of a new HIV diagnostic testing algorithm - United States, 2011-2013. MMWR 2013, 62(24):489-494. CDC.
6. Food and Drug Administration Approval letter - PMA supplement for multispot HIV-1/HIV-2 rapid test 2013, March, Available at, [accessed 15.06.13]. http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/PremarketApprovalsPMAs/ucm357028.htm.
7. Bio-Rad Laboratories Multispot HIV-1/HIV-2 rapid test, revised package insert 2013, Bio-Rad Laboratories, Redmond, WA.
8. CLSI Criteria for laboratory testing and diagnosis of human immunodeficiency virus infection; approved guidelines. CLSI document M53A 2011, Clinical and Laboratory Standards Institute, Wayne, PA.
9. Abbott Laboratories Architect HIV Ag/Ab combo, package insert 2010, Abbott Laboratories, Abbott Park, IL.
10. Owen S.M., Yang C., Spira T., et al. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol 2008, 46(5):1588-1595.
11. Patel P., MacKellar D., Simmons P., et al. Detecting human immunodeficiency virus infection using 3 different screening assays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med 2010, 170(1):6-8.
12. Masciotra S., McDougal J.S., Feldman J., et al. Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections. J Clin Virol 2011, 52(Suppl 1):S17-S22.
13. Delaney K.P., Heffelfinger J.D., Wesolowski L.G., et al. Performance of an alternative laboratory-based algorithm for HIV diagnosis in a high-risk population. J Clin Virol 2011, 52(Suppl 1):S5-S10.
14. Wesolowski L.G., Delaney K.P., Hart C., et al. Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors. J Clin Virol 2011, 52(Suppl 1):S45-S49.
15. Pandori M.W., Hackett J., Louie B., et al. Assessment of the ability of a fourth generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting. J Clin Microbiol 2009, 47:2639-2642.
16. Torian L.V., Forgione L.A., Punsalang A.E., et al. Comparison of multispot EIA with western blot for confirmatory serodiagnosis of HIV. J Clin Virol 2011, 52(Suppl 1):S41-S44.
17. Styer L.M., Sullivan T.J., Parker M.M. Evaluation of an alternative supplemental testing strategy for HIV diagnosis by retrospective analysis of clinical HIV testing data. J Clin Virol 2011, 52(Suppl 1):S35-S40.
18. Nasrullah M., Wesolowski L.G., Meyer W.A., et al. Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithm. AIDS 2013, 27:731-737.
19. Fiebig E.W., Wright D.J., Rawal B.D., et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003, 17:1871-1879.
20. Bennett S.B. HIV single stage testing: integration and maximization of resources by reducing time between HIV diagnosis and treatment. Presented at 2012 HIV Diagnostics Conference; December 11-14, Atlanta, GA 2012.